Michael barnett, Jacob Barnett's father

New York, Feb 5 Due to unequal distribution, people over the age 65 at the highest risk for severe Covid-19 have often been the least likely to receive monoclonal antibodies (mAbs), according to new research.Monoclonal antibodies are very effective at treating mild to moderate Covid-19 infection among non-hospitalised patients. But during the pandemic, mAbs have been in short supply."Monoclonal antibodies should first go to patients at the highest risk of death from Covid-19, but the opposite happened the healthiest patients were the most likely to get treatment," said Michael Barnett, Assistant Professor at Harvard T.H. Chan School of Public Health."Unfortunately, our federal and state system for distributing these drugs has failed our most vulnerable patients," he added.In the study, published online in JAMA, the team looked at data from more than 1.9 million Medicare beneficiaries who had been diagnosed with Covid-19 between November 2020 and August 2021.They found that among Medicare beneficiaries who weren't hospitalised or who didn't pass away within seven days of their diagnosis, only 7.2 per cent received mAb therapy.The likelihood of receiving mAbs was higher among those with fewer chronic conditions 23.2 per cent of those with no chronic conditions received mAbs, versus people with several chronic conditions, respectively."We need new approaches to prevent these inequities from happening again with newer treatments on the horizon," said Barnett.According to health experts, the highly effective therapy shouldn't be used unnecessarily on people.It should be used only among those above 65 years, with a Body Mass Index higher than 35, diabetics, chronic kidney disease patients, immunosuppressed individuals.It can also be used among people below 55, if they are patients of hypertension, chronic lung disease; and even in children aged below 12 years, and having a BMI higher than 35.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Salman Khan

Michael BarnettFOLLOW

Michael barnett, Latest News

Health :Highest risk patients for severe COVID-19 least likely to get monoclonal antibodies, says study

Ever since the COVID-19 pandemic hit the world, researchers have been giving every possible information to help in better treatment. According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likel ...

Health :Severe Covid patients had less access to monoclonal antibody therapy

New York, Feb 5 Due to unequal distribution, people over the age 65 at the highest risk for ... ...